Core Scientific (CORZ) Accounts Payables (2021 - 2026)

Core Scientific has disclosed Accounts Payables across 6 years of filings, most recently posting $112.4 million for Q2 2026.

• In Q2 2026, Accounts Payables fell 47.75% year-over-year to $112.4 million; the TTM figure through Jun 2026 stood at $112.4 million (down 47.75% YoY), while the FY2025 annual figure was $126.1 million, up 554.59% from the prior year.
• Accounts Payables came in at $112.4 million for Q2 2026 at Core Scientific, down from $218.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $218.9 million in Q1 2026 to a low of $6.3 million in Q1 2025.
• Average Accounts Payables over 5 years is $77.2 million, with a median of $47.9 million recorded in 2023.
• Year-over-year, Accounts Payables soared 18028.55% in 2022 and plunged 87.55% in 2024.
• Over 5 years, Accounts Payables stood at $53.6 million in 2022, then surged by 188.49% to $154.8 million in 2023, then sank by 87.55% to $19.3 million in 2024, then surged by 554.59% to $126.1 million in 2025, then retreated by 10.89% to $112.4 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $112.4 million in Q2 2026, $218.9 million in Q1 2026, and $126.1 million in Q4 2025.